Drug

Bio Roundup: SeaGen Scores, Dyne's Debut, Microbiome Moves & More

1 month ago   |   By Xconomy

Gilead Sciences CEO Daniel O'Day has spoken openly about acquisitions as a way to build up the company's drug pipeline. This week, it made its biggest buy yet. The $21 billion Immunomedics acquisition brings to Gilead a cancer drug that many analysts project will become a blockbuster seller. Some of those analysts think Gilead might have overpaid but the company says there were competing offers. The drug, sacitizumab govitecan , is what's called an antibody drug conjugate. This drug class has seen a lift in recent years. Four years ago, there were just three FDA-approved ADCs. The FDA has...
Read more ...

 


Search by Tags

   Drug      Cancer      Drugs      Science      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Philadelphia Blog Main      Philadelphia Top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      AbbVie      Adicet Bio      Allergan Aesthetics      Alzheimer's disease      Amgen      Aravive      AstraZeneca      Athira Pharma      Attralus      BioNtech      Biotech      Boehringer Ingelheim      Cancer      Cancer Drugs      Charles Hughes-Jones      Chiesi Farmaceutici      Cholestatic Liver Diseases      Christian Antoni      Click Therapeutics      COVID-19      Cullinan Oncology      Cygnal Therapeutics      Cystic Fibrosis      Daniel Hoy      Daniel O'Day      David Dismuke      David Hava      Deals      Diabetic Macular Edema      Diagnostics      Dicerna Pharmaceuticals      Dogma Therapeutics      Dyne Therapeutics      Ed Hedrick      Eli Lilly      EQRx      Escape Bio      Escient Pharmaceuticals      Finch Therapeutics      Forge Biologics      Gene editing      Gilead Sciences      Graphite Bio      Hepatitis B      Hepatitis C      Hexagon Bio      HIV      Immunomedics      Lava Therapeutics      Leonard Blum      Life Sciences      Ling Zeng      Marinus Pharmaceuticals      Mark Rothera      Medical Device      Merck      Metacrine      Microbiome      Miragen      ModeRNA      Neoantigens      Neogene Therapeutics      NeuMoDx Molecular      Neurodegenerative Disorders      Nick Harvey      Nicole Sweeny      Novartis      Novo Ventures      Olema Oncology      Oncorous      Osteoarthritis      OxyContin      Pacific Biosciences      Palleon Pharmaceuticals      Pfizer      Praxis Precision Medicines      Purdue Pharma      Qiagen      Questa Capital      Renato Skerlj      Reshma Rangwala      Rona Anhalt      Sacitizumab govitecan      Sanofi Ventures      Sean Bohen      Seattle Genetics      Silence Therapeutics      Stanford University      Startups      Stemson Therapeutics      Susan Kim      Synlogic      Synthekine      Systemic amyloidosis      Takeda Pharmaceutical      Terry Lo      The Column Group      Trevi Therapeutics      Unity Biotechnology      Uremic pruritus      Vedanta Biosciences      Vertex Pharmaceuticals      Vizgen      Volastra Therapeutics      X4 Pharmaceuticals      XWPharma      Yann Mazabraud  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Four months in, Baker lab hits the ground running and won't be stopping...

Four months in, Baker lab hits the ground running and won't be stopping anytime soon

Post doctorate Harim Tavares from the Baker lab works in “the hood,” which is a space used to prevent researchers and other outside factors from contaminating cells. By Lauren... Read more ...

Learning From History

Learning From History

Sung-Hwan Cho, a research scientist in the Gary Stacey lab, checks in on the arabidopsis plants that he uses in his purinergic signaling experiments. | photo by Lauren Hines... Read more ...

A Major Milestone for an Underground Dark Matter Search Experiment

A Major Milestone for an Underground Dark Matter Search Experiment

LZ's central detector, pictured here during assembly, is located inside a large water tank on the 4850 Level of Sanford Lab. LZ will search for theorized dark matter particles... Read more ...

LaserNetUS High-Power Laser Consortium, Including Berkeley Lab, Receives...

LaserNetUS High-Power Laser Consortium, Including Berkeley Lab, Receives $18M From the U.S. DOE

Berkeley Lab's BELLA Center houses the BELLA petawatt laser, shown here, and a 100-terawatt-class laser. Note: This release was adapted from an original release prepared by... Read more ...

IAmScience Karl Kerns

IAmScience Karl Kerns

By Becca Wolf | Bond LSC It's all about the journey and Karl Kerns has been places. Originally from a small town in southwestern Iowa, Kerns did his undergrad years at Iowa... Read more ...

IAmScience Alana Rodney

IAmScience Alana Rodney

By Lauren Hines | Bond LSC Research assistant Alana Rodney walked into her high school science class a few years ago expecting to fill another credit. However, it was there... Read more ...

Regulators Classify Gene-Edited Rice Varieties with Disease Resistance as...

Regulators Classify Gene-Edited Rice Varieties with Disease Resistance as Equivalent to Conventional Varieties

Crops resist bacterial leaf blight; ruling clears path to provide smallholder farmers with a safe, affordable option for preventing destructive disease A farmer works on paddy... Read more ...

Finding a Link between Xenoestrogens and Autism

Finding a Link between Xenoestrogens and Autism

California mice | photo by Roger Meissen, Bond LSC By Becca Wolf | Bond LSC It's hard to see a family member treated differently because of a behavior disorder, but those with... Read more ...

IAmScience Norma Castro-Guerrero

IAmScience Norma Castro-Guerrero

By Becca Wolf | Bond LSC If you like your work, you won't ever work a day in your life. That's the case for Norma Castro-Guerrero, a research scientist in David Mendoza's lab... Read more ...

Plant vs. Pathogen

Plant vs. Pathogen

Research scientist Jianbin Su studies the immune system in lettuce on the third floor of the Bond Life Science Center. By Lauren Hines | Bond LSC Scientist Jianbin Su's... Read more ...